Background: The prevalence of dementia is increasing rapidly. People with dementia
amongst others. [3] [4] [5] [6] The cognitive impairment characteristic of dementia may result in a lack of capacity to safely self-administer medication. 7, 8 Despite people with dementia being particularly susceptible to adverse drug events, they are commonly prescribed complex medication regimes and on average receive five different medicines. 7, 9 Medication management "is the entire way that medicines are selected, procured, delivered, prescribed, administered and reviewed to optimize the contribution that medicines make to producing informed and desired outcomes of patient care". 10 With increasing cognitive impairment, the core symptom of dementia, medication management is often shifted from the personal responsibility of the person with dementia to the control of formal (paid) or informal (family) carers particularly with complex regimens. [11] [12] [13] [14] [15] Informal carers often have a key role in ensuring safe and effective medication use as they may conduct up to 10 medication management activities every day, including awareness of and managing side-effects, and decisions to administer medication. 16, 17 Previous research has identified the role of informal carers as advocates and their potential contribution to patient safety. 18 Unlike health professionals, family and friends who are informal carers may not receive any training or have access to evidence-based information to appropriately support medication management. 17, 19 In fact, informal carers may not feel equipped for such an augmented role which they can find burdensome and stressful and this in turn may affect the informal carer's and the person with dementia's quality of life. [20] [21] [22] [23] [24] Without the support and collaboration of health professionals involved, informal carers may struggle to adequately support medication management especially of complex regimes. 8 However, some healthcare professionals lack time and awareness of the administration practicalities and the realities of informal carers and people with dementia. 25, 26 Furthermore, the information about medication regimens, provided by health-care professionals, can be complex and sometimes is not directly communicated to the informal carer due to the restriction of confidential information. 17, 19, 26 The role of community pharmacists is changing from being focused on the supply of medicines to providing clinical services. 27, 28 These services are focused on helping patients obtain the optimal benefit from prescribed medication by advising other clinicians and working directly with patients and others. [29] [30] [31] [32] The change in role is supported by national and international policy. 29, 33 The available literature argues that community pharmacy services available for people with dementia are poorly developed and the need for further research on ways to optimize medication management in people with dementia living in the community has been identified. 25, 34 It is important then to explore the perspectives of the key stakeholders, including informal carers and people with dementia, to understand how community pharmacists can support people with dementia living in the community with safe medication management. The objectives of the study were to describe and understand the key challenges, in relation to medication issues, experienced by people with dementia and their informal carers dwelling in the community, and the potential role of community pharmacists.
| METHODS

| Design
An exploratory qualitative study design that followed Consolidated
Criteria for Reporting Qualitative studies (COREQ) guidelines 35 was employed (see appendix for further details). A focus group conducted at the Alzheimer's Society and involving informal carers had previously identified the need for research in this area. 26 
| Participants and recruitment
Participants were recruited from the Alzheimer's Society, Dementia UK, local General Practice (GP) surgeries, professional networks and local dementia support groups (including a support group for people with dementia from the Black and Minority Ethnic [BME] community in Yorkshire). The institutions were contacted by LA and IM via telephone and email and were enquired about their willingness to collaborate in advertising the study. Recruitment was also conducted through snowball effect as contacts were requested to suggest other people with dementia, informal carers and HSCPs who might be willing to take part in this study.
| Data collection
Semi-structured face-to-face interviews were conducted. Two interview guides were used: one for people with dementia and their informal carers and one for HSCPs (see appendix for further details). This was the selected type of interview as it gives participants the opportunity to expand their answers freely and to provide in-depth reflections about their lived experiences. Furthermore, it allowed obtaining data that were suitable for conducting a Framework analysis. On three occasions, both the informal carer and the person with dementia were together in the room during the interview. This allowed the person with dementia to provide further insight into what the informal carer was saying. Each interview lasted between 30 and 60 minutes.
Interpreters from the same community were used for all the interviews with informal carers from the BME community.
| Inclusion criteria
Informal carers were eligible if:
• They had provided or still provide some sort of assistance with medication management to a person who has been diagnosed with dementia and is living in the community;
• Did not receive any sort of payment (excluding receipt of carers' allowance).
HSCPs were eligible if:
• They had been in contact with or had been providing assistance to people with dementia
| Data analysis
A qualitative framework analysis was undertaken in order to explore the experiences and perspectives of the participants. Framework analysis, which has been specifically designed for applied qualitative research that commences deductively from specified aims and objectives, was used to organize and make sense of the data. 36,37 NVIVO software was used to manage the data.
The transcripts were transcribed verbatim. TM and IM independently reviewed the transcripts. Disagreements on the interpretation and analysis of the data were then discussed between TM and IM. Any disagreements or differences in interpretation of the data between TM and IM were resolved, as necessary, with discussions involving the wider team (with AH the final arbiter) until consensus was achieved. A systematic cross-comparison analysis was undertaken by TM, and reviewed by IM to identify the similarities and differences between the different participants and to develop a set of themes which represent the whole corpus of data. TM and IM then discussed and agreed the final structure of the matrix for the analysis. 
| RESULTS
| The role of pharmacists
HSCPs identified the role of pharmacists in giving advice on medication.
However, informal carers and people with dementia tended to focus on practical aspects of the role, such as home delivery of medication, and viewed their role in terms of the supply of medication without mention- The challenges associated with medication management for people with dementia, their informal carers and the wider society can have potentially serious consequences. There is an increased risk of people with dementia experiencing a medication error, as clearly seen in the accounts from both HSCPs and carers, and previously identified. 40 Making sure that their loved one takes the right medication at the right time places a significant emotional burden on the informal carer, which is not always acknowledged by the HSCP. Additionally, if informal carers fail to cope, this has wider implications for society because further resources such as admission to residential care may be required.
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Other research on the challenges for informal carers in the management of Behavioural and Psychological Symptoms of Dementia (BPSD) also found a 'sense of shame' if the carers failed to cope and that the burden is often hidden from HSCPs. 38, 39 As far as we are aware, this is the first study that has focused on the barriers to community pharmacists supporting informal carers of people with dementia. Other studies have found barriers to a more clinical role for community pharmacists in the management of BPSD 28 and pain in people with dementia. 41 Similar to our research, the pharmacists in these studies believed that a lack of training and multidisciplinary working and lack of access to clinical records inhibited their input. 28, 41 Equally importantly, we found, like other research, that informal carers tended to view the role of pharmacists in terms of medication supply.
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Other studies have identified high levels of polypharmacy with potentially inappropriate prescribing in people with dementia ranging from 22% 4 to 81.5% of participants. 6 We found that medication review focussing on simplifying the regimen might be helpful, particularly if delivered in the home environment. However, a systematic review found that pharmacist-led chronic disease management increased the complexity of the medication regimen. 42 Ultimately, it is essential that HSCPs adopt a person-centred approach and pay attention to the challenges that informal carers and people with dementia face. This should include exploring ways to reduce any burden on informal carers associated with managing medication.
More generally, medicine optimization -defined as a 'personcentred approach to safe and effective medicines use, to ensure people obtain the best possible outcomes from their medicines' -has been identified a key priority within primary care. 43, 44 Further research on how to improve outcomes from medication and deliver medicine optimization is needed. 44 Deprescribing which is considered to be 'the process of withdrawal of inappropriate medication, supervised by a health-care professional with the goal of managing polypharmacy and improving outcomes' may represent a promising approach to medicine optimization. 45 However, evidence on the impact of deprescribing in older people is equivocal and further evidence from controlled studies is required. 
| Implications for clinicians and policymakers
Clinicians and policymakers need to be aware of the challenges involved and that even informal carers who do not report difficulties may be experiencing an emotional burden. Evidence-based guidelines need to consider this burden, which is worsened as the complexity of the regimen increases. There is a potential for community pharmacists to work outside the 'four walls' of the community pharmacy in order to support people with dementia and their informal carers manage their medication. 47 This 'work without boundaries' should include medication reviews in the patient's home, needs full access to clinical records and be coordinated with other medication optimization activity. 48 Whilst home-based medication reviews are occurring in some areas, this research found inconsistencies between regions. This need to review medication in the patient's own home would equally apply to practice-based pharmacists.
| Strengths and weaknesses
The study has a number of potential strengths. Data were triangulated from the perspectives of different HSCPs, informal carers and people with dementia. Participants were recruited from various locations and data saturation was achieved for the complete set of interviews, based on criteria from Fusch et al. 49 Like all research, there are limitations. Findings are context-bound to the participants and study setting, like all qualitative research. 50 Although we believe that the testimonies from the participants were particularly rich in content, as data were obtained from face-to-face interviews, we cannot avoid the possibility that participants may have given socially desirable responses. Only a limited number of participants from the BME community were interviewed.
| Future research
Further research would benefit from exploring the perspectives of a more diverse sample including people from the BME community; this study only included people from the South Asian BME community, and people with dementia living alone. A future project could also fol- is an issue, which should receive priority in terms of funding. Informal carers may also not be aware of this potential expanded clinical role.
Community pharmacists would need to develop this role within a multidisciplinary framework with access to full clinical records.
People with dementia are amongst the most vulnerable members of society with needs over and above people with no health issues.
They therefore need additional support, which needs to be recognized by commissioners of services. Appropriate care pathways should be established to provide this support; community pharmacists can be a key element of these pathways. 
APPENDIX Demographic Details of Participants
INTRODUCTION
Before we begin this interview, could you confirm whether you are caring for someone with dementia?
Thank you for taking part in this interview, I really do appreciate the time you have given. Before we begin, I want to make it clear that if you wish to skip any question(s) during the interview, or if you want to stop the interview, all you have to do is say; you do not need to give any explanation for doing so.
Are you happy for me to begin?
Can you tell me a bit about yourself? For example, do you have family or do you work?
Can you describe what a typical day involves for you?
The next few questions are going to be in regard to medication.
(If people with dementia) Can you describe to me any practical issues/concerns (if any) you find with taking medication?
(If carer) Can you describe to me any practical issues/concerns (if any) you find with assisting somebody with their medication?
Can you describe to me any strategies you use to organize medication?
Prompt: From sorting your medication to taking it or assisting someone to take it; are there any particular methods/procedures you use to do this?
In this next section, I am going to ask a few questions with regard to taking (if interviewing the person with dementia) or assisting somebody
(if the carer) in taking medication. I want to remind you that these questions are to help us better our understanding of how people feel about medication. Your replies will be treated so that no one will be able to identify that these are your answers.
(If person with dementia) Can you tell me about a time, if any, you have decided not to take your prescribed medication?
(If carer) Can you tell me about a time, if any, you have chosen to not give prescribed medication to your (whatever the relationship)?
Prompt: Do you think that people should always take their prescribed medication?
What would you describe as the benefits of taking medication?
Prompt: In your opinion, are there any benefits to not taking medication?
Can you think of any reasons why people would not take their prescribed medication?
The next section of questions will be about your experiences with medication:
In your opinion, does managing your medication affect your daily life?
Have you had any changes to medication over time?
If yes, can you tell me a bit about that and how it made you feel? Prompt: What health-care professional do you think would be most helpful in offering this support? An exploratory, qualitative study was conducted employing semi-structured interviews. Data were analysed using framework analysis.
How were participants selected?
• 
How many people refused to participate or dropped out?
None.
Where was the data collected?
The 
Were repeat interviews carried out?
No interviews were repeated.
Did the research use audio or visual recording to collect the data?
A Dictaphone was used to record the interviews. Data were transcribed verbatim.
Were field notes made during and/or after the interview or focus group?
Additional notes were made during the interviews. 
What was the duration of the interviews or focus group?
Was data saturation discussed?
Data saturation was reached and discussed amongst all co-authors.
Were transcripts returned to participants for comment and/or correction?
Transcripts were not returned to the participants, but potential themes were discussed between all co-authors. 
Did authors provide a description of the coding tree?
No.
Were themes identified in advance or derived from the data?
Themes were derived from the data. Three key concepts were elicited from the data with subthemes within these three themes.
What software, if applicable, was used to manage the data?
NVIVO software was used to manage the data.
Did participants provide feedback on the findings?
Participants did not provide feedback.
Were participant quotations presented to illustrate the themes/ findings? Was each quotation identified?
Extracts presented in the results section were drawn directly from the transcripts, which are recordings of the interviews.
Was there consistency between the data presented and the findings?
Yes there was consistency between the data presented and the findings.
Were major themes clearly presented in the findings?
Three key concepts were elicited from the data with subthemes within these three themes, and all three themes were discussed in the results section.
Is there a description of diverse cases or discussion of minor themes?
Yes, diverse cases have been discussed and the differences between the interview data from the carers and HSCPs. When relevant, minor themes were discussed.
